drug interactions

Bumetanide: Ginseng may decrease the therapeutic effect of diuretic, bumetanide.

Digoxin: Changes in digoxin serum levels

Ethacrynic acid: Ginseng may decrease the therapeutic effect of diuretic, ethacrynic acid.

Furosemide: Ginseng decreases the therapeutic effect

Ginkgo biloba: Additive anticoagulant/antiplatelet effects may increase bleed risk. Concomitant therapy should be avoided.

Ketoprofen: Increased risk of bleeding due to additive anticoagulant properties of the two agents. Concomitant therapy should be avoided or monitored carefully for bleeding, bruising and altered mental status, which may be caused by CNS bleeds.

Nifedipine: Ginseng increases the effect and toxicity of nifedipine

Sulindac: Ginseng may enhance the anticoagulant effect of sulindac. Increased risk of bleeding, bruising and altered mental status due to CNS bleeds. Concomitant therapy should be avoided.

Tenecteplase: Increased risk of bleeding.

Tiaprofenic acid: Increased risk of bleeding due to additive antiplatelet properties of the two agents. Concomitant therapy should be avoided or monitored carefully for bleeding, bruising and altered mental status, which may be caused by CNS bleeds.

Tolmetin: Increased risk of bleeding due to additive antiplatelet properties of the two agents. Concomitant therapy should be avoided or monitored carefully for bleeding, bruising and altered mental status, which may be caused by CNS bleeds.

Trandolapril: Ginseng may antagonize the antihypertensive effect of Trandolapril. Monitor Trandolapril efficacy.

Urokinase: Increased risk of bleeding.

Warfarin: Additive anticoagulant effects increase the risk of bleeding. Concomitant therapy should be avoided.